Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?

被引：0
|
作者：
J. Jaime Alberty-Oller
Sarah Weltz
Antonio Santos
Kereeti Pisapati
Meng Ru
Christina Weltz
Hank Schmidt
Elisa Port
机构：
[1] Mount Sinai Hospital,Dubin Breast Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：281 / 286
页数：5
相关论文
共 50 条
  • [21] Variation in genetic mutations in breast cancer patients meeting NCCN criteria vs those who do not
    Whitworth, Pat
    Beitsch, Peter
    Baron, Paul
    Patel, Rakesh
    Rosen, Barry
    Simmons, Rache
    Smith, Linda
    Barbosa, Karen
    Coomer, Cynara
    Compagnani, Gia
    Holmes, Dennis
    Brown, Eric
    Gold, Linsey
    Kinney, Michael
    Grady, Ian
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 494 - 495
  • [22] Who Needs Genetic Testing for Breast Cancer?
    Pederson, Holly J.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (12): : 1480 - 1480
  • [23] Underdiagnosis of HBOC in breast cancer patients: Are genetic testing guidelines a tool or an obstacle?
    Beitsch, P.
    Whitworth, P.
    Baron, P.
    Rosen, B.
    Compagnoni, G.
    Simmons, R.
    Smith, L. A.
    Holmes, D.
    Brown, E.
    Gold, L.
    Clark, P.
    Coomer, C.
    Grady, I.
    Barbosa, K.
    Riley, L.
    Kinney, M.
    Lyons, S.
    MacDonald, H.
    Kahn, S.
    Ruiz, A.
    Patel, R.
    Curcio, L.
    Esplin, E.
    Yang, S.
    CANCER RESEARCH, 2019, 79 (04)
  • [24] Assessment of Compliance With NCCN Guidelines for Breast Cancer Patients Treated at a Comprehensive Cancer Center
    Dvorak, T.
    Constantino, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S541 - S541
  • [25] Investigation of posttreatment NCCN surveillance adherence for patients with endometrial cancer who developed recurrence
    Mayer, Christopher
    O'Connor, Reed
    Scott, Marla
    Li, Andrew
    Rimel, Bobbie
    Taylor, Kristin
    Manuel, Michael
    Kim, Kenneth
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S84 - S85
  • [26] Analysis of patients with two hereditary cancers (breast/ovarian or colon/endometrial) who met NCCN genetic testing criteria after their first cancer.
    Saam, Jennifer
    Moyes, Kelsey
    Arnell, Christopher
    Landon, Michelle
    Kaldate, Rajesh R.
    Strike, Brian
    Williams, Kayon
    Burbidga, Lynn Anna
    Abbott, Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Update: NCCN practice guidelines for the treatment of breast cancer
    Carlson, RW
    ONCOLOGY-NEW YORK, 1999, 13 (5A): : 41 - 66
  • [28] Update: NCCN practice guidelines for the treatment of breast cancer
    Carlson, RW
    Anderson, BO
    Bensinger, W
    Cox, C
    Davidson, NE
    Edge, SB
    Farrar, WB
    Goldstein, LJ
    Gradishar, WJ
    Lichter, AS
    Mccormick, B
    Nabell, LM
    Reed, EC
    Silver, SM
    Smith, MLP
    Somlo, G
    Theriault, RL
    Winer, EP
    ONCOLOGY-NEW YORK, 1999, 13 (11A): : 187 - 212
  • [29] Molecular Tests in Pancreatic Cancer: Critical Role of Molecular Testing, Expanding Access, and Adherence to the NCCN Guidelines for Pancreatic Cancer
    Jhala, Nirag
    Petersen, Jeffrey
    Jhala, Darshana
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (05): : 360 - 362
  • [30] NCCN breast cancer risk-reduction guidelines
    Carlson, R
    Barakat, R
    Bevers, T
    Daly, MB
    Edge, S
    Garber, JE
    Gradishar, W
    Mahoney, M
    Sellin, RV
    Shapiro, C
    Singletary, E
    Theriault, R
    Ward, J
    Whittemore, A
    Williams, C
    Winer, E
    ONCOLOGY-NEW YORK, 1999, 13 (11A): : 241 - 254
12345